Aligning sample size calculations with estimands in clinical trials with time-to-event outcomes

被引:0
|
作者
Fang, Yixin [1 ]
Jin, Man [1 ]
Wu, Chengqing [2 ]
机构
[1] Fang 1 North Waukegan Rd, N Chicago, IL 60064 USA
[2] 55,Challenger Rd STE 501, Ridgefield Pk, NJ 07660 USA
关键词
AND PHRASES; Clinical trials; Estimand; current events; Sample size; Time-to-event;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The ICH E9(R1) guidance recommended a framework to align planning, design, conduct, analysis, and interpretation of any clincial trial with its objective and estimand. How to handle intercurrent events (ICEs) is one of the five attributes of an estimand and sample size calculation is a key step in the trial planning and design. Therefore, sample size calcula-tion should be aligned with the estimand and, in particular, with how the ICEs are handled. ICH E9(R1) summarized five strategies for handling ICEs, and five approaches have been proposed in the literature for sample size calculation when planning trials with quantitative and binary outcomes. In this paper, we discuss how to apply the five strategies to deal with ICEs in clinical trials with time-to-event outcomes and propose five approaches for sample size calculation that are aligned with the five strategies, respectively. AMS 2000 SUBJECT CLASSIFICATIONS: Primary 62N03, 62G10; secondary 62G99.
引用
收藏
页码:63 / 68
页数:6
相关论文
共 50 条
  • [1] Assurance calculations for planning clinical trials with time-to-event outcomes
    Ren, Shijie
    Oakley, Jeremy E.
    STATISTICS IN MEDICINE, 2014, 33 (01) : 31 - 45
  • [2] Sample size calculations for noninferiority trials for time-to-event data using the concept of proportional time
    Phadnis, Milind A.
    Mayo, Matthew S.
    JOURNAL OF APPLIED STATISTICS, 2021, 48 (06) : 1009 - 1032
  • [3] Editor's Note: Special Section on Estimands, Design and Analysis of Clinical Trials with Time-to-Event Outcomes
    Hamasaki, Toshimitsu
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (02): : 237 - 237
  • [4] Power and Sample Size Calculations for SNP Association Studies With Censored Time-to-Event Outcomes
    Owzar, Kouros
    Li, Zhiguo
    Cox, Nancy
    Jung, Sin-Ho
    GENETIC EPIDEMIOLOGY, 2012, 36 (06) : 538 - 548
  • [5] Statistical power and sample size calculations for time-to-event analysis
    Zurakowski, David
    Staffa, Steven J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2023, 166 (06): : 1542 - +
  • [6] Sample size formula for joint modelling of longitudinal and time-to-event data in clinical trials
    Matthew Powney
    Paula Williamson
    Ruwanthi Kolamunnage-Dona
    Trials, 14 (Suppl 1)
  • [7] Sample size adjustment designs with time-to-event outcomes: A caution
    Freidlin, Boris
    Korn, Edward L.
    CLINICAL TRIALS, 2017, 14 (06) : 597 - 604
  • [8] Sample size re-estimation without un-blinding for time-to-event outcomes in oncology clinical trials
    Lihong Huang
    Jianling Bai
    Hao Yu
    Feng Chen
    TheJournalofBiomedicalResearch, 2018, 32 (01) : 23 - 29
  • [9] A Bayesian approach for event predictions in clinical trials with time-to-event outcomes
    Aubel, Paul
    Antigny, Marine
    Fougeray, Ronan
    Dubois, Frederic
    Saint-Hilary, Gaelle
    STATISTICS IN MEDICINE, 2021, 40 (28) : 6344 - 6359
  • [10] Minimum sample size calculations for external validation of a clinical prediction model with a time-to-event outcome
    Riley, Richard D.
    Collins, Gary S.
    Ensor, Joie
    Archer, Lucinda
    Booth, Sarah
    Mozumder, Sarwar, I
    Rutherford, Mark J.
    van Smeden, Maarten
    Lambert, Paul C.
    Snell, Kym I. E.
    STATISTICS IN MEDICINE, 2022, 41 (07) : 1280 - 1295